IBD Live: Optimizing Treatment Now and in the Future

Learn expert recommendations on new and emerging IBD therapies in this series of 3 live Webinars with downloadable slides and audio.
David A. Schwartz, MD, FACG, AGAF

Downloadable Audio

Improve your ability to put your patients on the path to remission in IBD with this brief audio from our live program.

David A. Schwartz, MD, FACG, AGAF Released: September 7, 2018

Downloadable Slides

Improve your ability to put your patients on the path to remission in IBD with this downloadable slideset.

David A. Schwartz, MD, FACG, AGAF Released: August 30, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Celgene Corporation
Shire

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?